Published in Medical Patent Law Weekly, September 16th, 2009
In addition to enforcing advertising and promotion restrictions, the Center will oversee the FDA's execution of expanded authority under a new law that allows the FDA to set performance standards and review of premarket applications for new and modified risk tobacco products.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.